Vilon (L-Lys-L-Glu), a synthetic dipeptide bioregulator derived from the thymus gland. While “Violon” is a common misspelling, the clinical data for Vilon is well-documented in the field of peptide therapy and longevity.

Below is a report based on the available clinical data and biological research.

Product Overview

• Scientific Name: L-Lysyl-L-Glutamic acid (Lys-Glu)
• Classification: Thymic Peptide Bioregulator
• Core Function: Immune modulation and cellular regeneration via gene expression regulation.

Key Reported Benefits

Research into Vilon primarily focuses on its ability to reverse age-related cellular decline and support the immune system.

1. Cellular Longevity and Anti-Aging
   • Chromatin Reactivation: Data indicates that Vilon induces “deheterochromatinization” (unrolling) of DNA in older individuals. This essentially “turns back on” genes that have become silenced due to aging, allowing for renewed protein synthesis.
   • Telomere Support: While often used alongside Epitalon, Vilon specifically helps maintain cellular health by ensuring the thymus remains active, preventing the rapid “immunosenescence” (immune aging) typically seen in the elderly.
2. Immune System Modulation
   • Thymus Regeneration: It mimics the activity of natural thymic hormones, stimulating the production and maturation of T-lymphocytes (T-cells).
   • Inflammation Control: Clinical observations suggest it helps normalize the ratio of T-helper to T-suppressor cells, reducing chronic systemic inflammation.
3. Tissue Repair & Cancer Research
   • Wound Healing: Some data shows accelerated healing of skin burns and damaged tissues by increasing blood flow to the affected areas.
   • Oncology Research: In animal studies (notably by Khavinson et al.), Vilon has been shown to inhibit the growth of spontaneous tumors and significantly increase the mean lifespan of mice.

Scientific Data Summary

Feature	Research Data Finding
Gene Activation	Reactivates ribosomal genes in older people’s cells.
Lifespan Impact	Animal models showed up to a 25-30% increase in mean lifespan.
Tumor Suppression	Shown to decrease the incidence of spontaneous tumors in mice by modulating the immune response.
Toxicity	Classified as having extremely low toxicity due to its simple dipeptide structure.

Common Combinations

In 2026, Vilon is frequently paired with other bioregulators for a synergistic effect:

• Vilon + Epitalon: The “Gold Standard” for longevity; Vilon supports the immune system while Epitalon targets the pineal gland and telomeres.
• Vilon + BPC-157: Used for advanced recovery from surgery or chronic injury, combining immune-led healing with systemic tissue repair.

Note on Safety: While Vilon is considered highly bioavailable and safe in clinical research, it is still categorized as a “research chemical” in many jurisdictions. Always consult with a medical professional before beginning peptide therapy.